A major breakthrough in cancer study is emerging with the use of VHH fragments to re-engage damaged p53. This crucial malignant inhibitor protein is frequently inactivated in various kinds of malignancies, leading https://mysocialport.com/story7500379/vhh-fragments-reactivate-p53-a-potential-pathway-for-malignant-management